The Lancet Haematology in conversation with

Release Date

All Episodes

Julio Delgado and Valentín Ortiz-Maldonado

Dr Julio Delgado and Dr Valentín Ortiz-Maldonado join us to discuss the results of their phase 2 trial testing varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain.Click here to read the full article: https://www ... Show more

. 12min 4sec

Julio Delgado and Valentín Ortiz-Maldonado (Spanish version)

. 12min 55sec

Erica Kaye and Dylan Graetz discuss expert recommendations for the conduct and appraisal of qualitative research in haematology

Dr Erica Kaye and Dr Dylan Graetz join us to discuss the importance of qualitative research and how the whole research ecosystem can incorporate and support this type of research to help set the right research questions, and promote the patient voice.Click here to read the full a ... Show more

. 19min 40sec

Presented at ASH: API-CAT post-hoc analysis on predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated VTE

Professor Isabelle Mahé joins us to discuss the results of a post-hoc analysis of the API-CAT trial identifying predictors associated with clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism.Click here to read the full article ... Show more

. 9min 55sec

Presented at ASH 2025: EPCORE CLL-1 trial on epcoritamab monotherapy for Richter transformation

Arnon Kater joins Daniela Marin of The Lancet Haematology to discuss the phase 1b/2 EPCORE CLL-1 trial of epcoritamab monotherapy for Richter transformation, which is being presented at ASH 2025.Click here to read the full article: https://www.thelancet.com/journals/lanhae/articl ... Show more

. 14min 22sec